PL404583A1 - Związek kompleksowy srebra, sposób wytwarzania związku oraz zastosowanie związku - Google Patents
Związek kompleksowy srebra, sposób wytwarzania związku oraz zastosowanie związkuInfo
- Publication number
- PL404583A1 PL404583A1 PL404583A PL40458313A PL404583A1 PL 404583 A1 PL404583 A1 PL 404583A1 PL 404583 A PL404583 A PL 404583A PL 40458313 A PL40458313 A PL 40458313A PL 404583 A1 PL404583 A1 PL 404583A1
- Authority
- PL
- Poland
- Prior art keywords
- compound
- silver
- hydroxymethyl
- pyridine
- reaction medium
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 229910052709 silver Inorganic materials 0.000 title abstract 3
- 239000004332 silver Substances 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 title 1
- PTMBWNZJOQBTBK-UHFFFAOYSA-N pyridin-4-ylmethanol Chemical compound OCC1=CC=NC=C1 PTMBWNZJOQBTBK-UHFFFAOYSA-N 0.000 abstract 6
- 239000012429 reaction media Substances 0.000 abstract 3
- 238000002360 preparation method Methods 0.000 abstract 2
- 239000000376 reactant Substances 0.000 abstract 2
- 150000001412 amines Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 239000002798 polar solvent Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- -1 silver (I) compound Chemical class 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyridine Compounds (AREA)
Abstract
Wynalazek dotyczy związku kompleksowego srebra i 4-(hydroksymetylo)pirydyny o wzorze 1, sposobu wytwarzania tego związku oraz jego zastosowania do wytwarzania preparatu do hamowania rozwoju komórek chorobotwórczych, w profilaktyce lub leczeniu organizmu zwierzęcia lub człowieka. W sposobie wytwarzania stosuje się jako reagenty 4-(hydroksymetylo)pirydynę i związek srebra(I) co najmniej częściowo rozpuszczamy w środowisku reakcyjnym. Reagenty zestawia się w środowisku reakcyjnym zawierającym co najmniej jeden nie-aminowy rozpuszczalnik polarny w temperaturze 0-50°C, i prowadzi się reakcję przez 1-180 minut utrzymując temperaturę 0-50°C pobudzając mechanicznie środowisko reakcyjne, a następnie wydziela się związek kompleksowy srebra i 4-(hydroksymetylo)pirydyny.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL404583A PL404583A1 (pl) | 2013-07-08 | 2013-07-08 | Związek kompleksowy srebra, sposób wytwarzania związku oraz zastosowanie związku |
| EP14174623.0A EP2848608B1 (en) | 2013-07-08 | 2014-06-26 | Silver complex compounds, method for their production and their use |
| PL14174623T PL2848608T3 (pl) | 2013-07-08 | 2014-06-26 | Związki kompleksowe srebra, sposób wytwarzania związków oraz zastosowanie związków |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL404583A PL404583A1 (pl) | 2013-07-08 | 2013-07-08 | Związek kompleksowy srebra, sposób wytwarzania związku oraz zastosowanie związku |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL404583A1 true PL404583A1 (pl) | 2015-01-19 |
Family
ID=52102369
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL404583A PL404583A1 (pl) | 2013-07-08 | 2013-07-08 | Związek kompleksowy srebra, sposób wytwarzania związku oraz zastosowanie związku |
| PL14174623T PL2848608T3 (pl) | 2013-07-08 | 2014-06-26 | Związki kompleksowe srebra, sposób wytwarzania związków oraz zastosowanie związków |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14174623T PL2848608T3 (pl) | 2013-07-08 | 2014-06-26 | Związki kompleksowe srebra, sposób wytwarzania związków oraz zastosowanie związków |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP2848608B1 (pl) |
| PL (2) | PL404583A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL411078A1 (pl) * | 2015-01-27 | 2016-08-01 | Uniwersytet Medyczny w Łodzi | Związek kompleksowy srebra, sposób wytwarzania związku kompleksowego oraz zastosowanie związku kompleksowego |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100234339A1 (en) | 2007-05-31 | 2010-09-16 | Cse Incubation Ab | Silver(i) compounds and their use in pharmaceutical compositions for the treatment,prophylaxis and prevention of infections |
-
2013
- 2013-07-08 PL PL404583A patent/PL404583A1/pl unknown
-
2014
- 2014-06-26 PL PL14174623T patent/PL2848608T3/pl unknown
- 2014-06-26 EP EP14174623.0A patent/EP2848608B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2848608B1 (en) | 2017-12-20 |
| PL2848608T3 (pl) | 2018-05-30 |
| EP2848608A1 (en) | 2015-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20210064A1 (ar) | عملية لتحضير 5- فلورو-1h- بيرازولوبيريدينات مستبدلة | |
| TN2012000249A1 (en) | Pyrazine derivatives and their use in the treatment of neurological disorders | |
| JOP20190151B1 (ar) | مركبات أمينو - ترايازولو بيريدين واستخدامها في علاج سرطان | |
| PH12013501600A1 (en) | Novel heterocyclic derivatives | |
| MX2012001070A (es) | Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurologicos. | |
| BR112013033182A2 (pt) | compostos imidazopiridinil-aminopiridina substituída | |
| EA201200318A1 (ru) | Гетероциклические оксимы | |
| EA201490647A1 (ru) | Производные бензотиазол-6-илуксусной кислоты и их применение для лечения вич-инфекции | |
| EP4635568A3 (en) | Compounds, salts thereof and methods for treatment of diseases | |
| NZ707859A (en) | Inhibitors of sodium glucose cotransporter 1 | |
| EA201692095A1 (ru) | Имидазо[4,5-c]хинолин-2-оновые соединения и их применение в лечении рака | |
| HK1245677A1 (zh) | 用於治疗炎症和癌症的杂环itk抑制剂 | |
| EA201491672A1 (ru) | Гетероциклильные соединения как ингибиторы mek | |
| PH12015501585A1 (en) | Manufacturing process for pyrimidine derivatives | |
| MX2015014234A (es) | Derivados 2-aminopirido-[4,3-d]pirimidin-5-ona y su uso como inhibidores de wee-1. | |
| TR201902249T4 (tr) | Trpa1 modülatörleri olarak faydalı ornatık heterosiklik sülfonamit bileşikleri. | |
| EA201200260A1 (ru) | Гетероциклические гидразоны и их применение для лечения рака и воспаления | |
| MX2017003470A (es) | Inhibidores macrociclicos de cinasa lrrk2. | |
| MX2015013148A (es) | Nuevos compuestos de bencensulfonamida, metodo para sintetizar los mismos, y uso de los mismos en medicina asi como tambien en cosmeticos. | |
| NZ629914A (en) | New derivatives of 5-aminolevulinic acid and their use as photosensitizing agents | |
| MX2023002589A (es) | Derivados de fumagilol y polimorfos de los mismos. | |
| MX2015013936A (es) | Compuestos de pirimidina condensada sustituida. | |
| MX2011013869A (es) | Agentes antihelminticos y su uso. | |
| CY1117723T1 (el) | Παραγωγα στερολης, μεθοδος για την παρασκευη των ιδιων, φαρμακευτικες συνθεσεις οι οποιες περιεχουν τα ιδια και χρηση αυτων για την αγωγη πολλαπλων γλοιοβλαστωματων | |
| WO2017223514A8 (en) | Lxr inverse agonists for treatment of cancer |